Zenabis submits site evidence package to Health Canada for Langley facility
Zenabis Global Inc. (TSX:ZENA)submitted its site evidence package to Health Canada for the first phase of Site A at its Zenabis Langley plant.
Construction of Zenabis Langley's first 50,000-square-foot flower room is substantially complete, as is 49,000 square feet of support space, which includes drying and trimming rooms, processing rooms, a packaging room, offices, change rooms and storage space.
Construction of the remaining five flower rooms and additional support space totalling 380,000 square feet is on track for substantial completion in August 2019.
The site evidence package submission is expected to be the final step required by Zenabis to obtain a license to cultivate cannabis at Zenabis Langley.
Zenabis expects that the facility will have a licensed annual cultivation capacity of 9,900 kg of dried cannabis when the cultivation license is granted, at which time Zenabis plans to submit a license amendment for the facility's remaining five flower rooms representing 86,200 kg of cultivation capacity.
"Zenabis Langley's design capacity represents more than 70% of the total annual capacity of 131,200 kg of dried cannabis that we plan to reach in the third quarter," Andrew Grieve, CEO of Zenabis, said in a statement. "As the expected final step in Health Canada's cultivation licensing process, submission of the site evidence package is an important milestone.”
Mr. Grieve said that after completing the licensing in Zenabis Langley, together with its licensing achievements in Stellarton and Atholville this year, Zenabis expects to be a significant producer of cannabis in Canada.
“With existing distribution into eight provinces, one territory, a number of medical channels, and meaningful wholesale agreements and opportunities, Zenabis anticipates increased deliveries to such counterparties as harvests commence on its remaining capacity," he added.